Cargando…
Predictive Value of Annenxin A1 for Disease Severity and Prognosis in Patients with Community-Acquired Pneumonia
This prospective, single-center study evaluated the clinical utility of annenxin (Anx)A1 level as a biomarker for determining the severity of illness and predicting the risk of death in hospitalized patients with community-acquired pneumonia (CAP). A total of 105 patients (53 with severe [S]CAP, 52...
Autores principales: | Gu, Minghao, Han, Xiudi, Liu, Xuedong, Sui, Fengxiang, Zhang, Quansan, Pan, Shengqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914428/ https://www.ncbi.nlm.nih.gov/pubmed/36766501 http://dx.doi.org/10.3390/diagnostics13030396 |
Ejemplares similares
-
Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network
por: Han, Xiudi, et al.
Publicado: (2022) -
Validation of a Prediction Rule for Prognosis of Severe Community-Acquired Pneumonia
por: Leroy, Olivier, et al.
Publicado: (2008) -
Predictive value of copeptin as a severity marker of community-acquired pneumonia
por: Mohamed, Gamal Baheeg, et al.
Publicado: (2017) -
Comorbidities impact on the prognosis of severe acute community-acquired pneumonia
por: Vidal, Ana, et al.
Publicado: (2017) -
Value of syndromic panels in the management of severe community-acquired pneumonia
por: Burillo, Almudena, et al.
Publicado: (2022)